Inflammatory Bowel Disease News and Research

Latest Inflammatory Bowel Disease News and Research

New method to study gut microbiome opens door to new medical opportunities

The more diverse species in your gut, the better it is for your health. Now an international team led by the Hudson Institute of Medical Research has found a way to determine which species are important and how they interact to create a healthy microbiome.

20 Oct 2023

Does inflammatory bowel disease have a causal relationship with extracolonic tumors?

Whether inflammatory bowel disease (IBD) is causally related to extracolonic cancers.

17 Oct 2023

Immersive VR interventions effective in reducing pain and distress among cancer patients

Immersive virtual reality - digital technology that allows a person to experience being physically present in a non-physical world - seems to ease the pain and distress felt by patients with cancer, suggests a pooled data analysis of the available evidence published in BMJ Supportive & Palliative Care.

16 Oct 2023

Research suggests potential connection between gut bacteria and onset of colorectal lesions and cancers

New research has identified significant variations in the gut microbiome of individuals who developed pre-cancerous colonic lesions, suggesting a potential connection between gut bacteria and the onset of colorectal lesions and cancers.

15 Oct 2023

Supercharge your kale juice: Fermentation ramps up antioxidant and anti-inflammatory powers

Fermenting kale juice with Limosilactobacillus strains boosts its antioxidant and anti-inflammatory properties, according to a new study in the journal Antioxidants. The research suggests that this bacteria-enhanced juice could offer enhanced health benefits, including elevated levels of beneficial phytonutrients like quercetin and kaempferol.

15 Oct 2023

BIOHIT HealthCare to host webinar exploring TDM in gastrointestinal medicine

BIOHIT HealthCare is excited to announce its upcoming webinar entitled Proactive vs reactive therapeutic drug monitoring in inflammatory bowel disease (IBD).

From BIOHIT HealthCare Ltd 13 Oct 2023

IL-17: The molecule that could revolutionize autoimmune and cancer treatments

The research paper explores the multifaceted role of the IL-17 family in immune response, covering everything from infection control to pathological conditions like autoimmune diseases and cancer. Future therapies may exploit IL-17's unique signaling pathways to offer more targeted and cost-effective treatments.

12 Oct 2023

Beyond the gut: Crohn's disease's oral clues for timely diagnosis

The oral manifestations of CD.

12 Oct 2023

Might a polyphenol-rich dietary approach hold the answers for managing inflammatory bowel disease?

Gut microbiota and macrophage-neutrophil interactions in the impact of dietary phenolic acids on intestinal inflammation.

11 Oct 2023

Inflammatory diseases don't boost clotting risks post-COVID, study reveals

Canadian researchers found that patients with immune-mediated inflammatory diseases (IMIDs) don't face a heightened risk of venous thromboembolism events after recovering from COVID-19 compared to those without IMIDs. However, certain comorbidities can influence this risk, emphasizing the importance of individualized patient care.

11 Oct 2023

Macrophages play a central role in intestinal cell renewal, study reveals

A research team from MedUni Vienna and the FWF-sponsored Special Research Area SFB F83 Immunometabolism has now demonstrated for the first time the central role of macrophages in the renewal of intestinal cells, which sheds light on the complex interplay between immune cells and tissue regeneration.

10 Oct 2023

Is there an association between psoriasis onset and risk of autoimmune disease?

Researchers evaluated new-onset autoimmune disease risk among individuals with new-onset psoriatic illness.

9 Oct 2023

Oral lipid nanoparticle drug shows promise for preventing colitis-associated cancer in mice

An oral lipid nanoparticle drug prevents tumor development in mice, suggesting this is a promising drug formulation for preventing colitis-associated cancer, according to a study led by researchers in the Institute for Biomedical Sciences at Georgia State University.

4 Oct 2023

Effectiveness of Lactobacillus in treating inflammatory bowel disease

The role of Lactobacillus in treating inflammatory bowel disease.

4 Oct 2023

Natural antibiotic thiostrepton reveals new hope for inflammatory bowel disease treatment

Researchers explored the therapeutic impact of Thiostrepton on experimental colitis by examining its effects on colon inflammation and determining its targets through various biochemical approaches.

28 Sep 2023

Yeast in the gut linked to Crohn's disease inflammation, opening new doors for treatment

New study in Nature Medicine links yeast cells in the gastrointestinal tract to abnormal immune responses causing inflammation in Crohn's disease patients. The research suggests that these yeast-reactive T-cells could be a potential therapeutic target, offering new avenues for treatment.

27 Sep 2023

Early feeding practices key to shaping lifelong oral microbiome

Research delves into the little-explored world of the infant oral microbiome, examining how early nutrition and environmental factors shape it. With implications for lifelong health, the research aims to guide future health recommendations, emphasizing the need for more longitudinal studies and advanced sequencing techniques.

26 Sep 2023

Study demonstrates novel role of Axin1 in mediating intestinal homeostasis and microbiota

A groundbreaking study conducted by Jun Sun's research team at the University of Illinois Chicago has revealed a new and critical role of Axin1 in regulating intestinal epithelial development and microbial homeostasis.

22 Sep 2023

Flagellin immunization protects mice from detrimental effects of dietary emulsifiers

In a new study, mice whose immune systems were trained against the microbial protein flagellin did not experience the usual detrimental effects of ingesting food additive emulsifiers, pointing to a potential new way to combat various chronic inflammatory diseases.

20 Sep 2023

Save billions or stick with Humira? Drug brokers steer Americans to the costly choice

Tennessee last year spent $48 million on a single drug, Humira — about $62,000 for each of the 775 patients who were covered by its employee health insurance program and receiving the treatment.

19 Sep 2023

Inflammatory Bowel Disease News and Research

Latest Inflammatory Bowel Disease News and Research

New method to study gut microbiome opens door to new medical opportunities

Does inflammatory bowel disease have a causal relationship with extracolonic tumors?

Immersive VR interventions effective in reducing pain and distress among cancer patients

Research suggests potential connection between gut bacteria and onset of colorectal lesions and cancers

Supercharge your kale juice: Fermentation ramps up antioxidant and anti-inflammatory powers

BIOHIT HealthCare to host webinar exploring TDM in gastrointestinal medicine

IL-17: The molecule that could revolutionize autoimmune and cancer treatments

Beyond the gut: Crohn's disease's oral clues for timely diagnosis

Might a polyphenol-rich dietary approach hold the answers for managing inflammatory bowel disease?

Inflammatory diseases don't boost clotting risks post-COVID, study reveals

Macrophages play a central role in intestinal cell renewal, study reveals

Is there an association between psoriasis onset and risk of autoimmune disease?

Oral lipid nanoparticle drug shows promise for preventing colitis-associated cancer in mice

Effectiveness of Lactobacillus in treating inflammatory bowel disease

Natural antibiotic thiostrepton reveals new hope for inflammatory bowel disease treatment

Yeast in the gut linked to Crohn's disease inflammation, opening new doors for treatment

Early feeding practices key to shaping lifelong oral microbiome

Study demonstrates novel role of Axin1 in mediating intestinal homeostasis and microbiota

Flagellin immunization protects mice from detrimental effects of dietary emulsifiers

Save billions or stick with Humira? Drug brokers steer Americans to the costly choice

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

The evolution of OCT for retinal imaging and disease intervention

Inflammatory Bowel Disease News and Research

Latest Inflammatory Bowel Disease News and Research

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

The evolution of OCT for retinal imaging and disease intervention

Newsletters you may be interested in